Evidence map›Paper›PMID 38250607›Full record

ArticleInternational journal of medical sciences2024

LncRNA HOTAIR Inhibits miR-19a-3p to Alleviate Foam Cell Formation and Inflammatory Response in Atherosclerosis.

Heming Chen, Xiaoyi Li, Weiqun Chen, Tangwei Wu, Shuiyi Liu

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of medical sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Lipid metabolism in homeostasis and disease.Signal transduction and targeted therapy · 2026
    Review
  2. Review
  3. Review
  4. Research progress of stem cells in the treatment of atherosclerosis.Frontiers in cell and developmental biology · 2025
    Review
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Heming ChenDepartment of Cardiovascular Surgery, The Second XiangYa Hospital, Central South University, Changsha, Hunan, 410011, China.
Xiaoyi LiDepartment of Medical Laboratory, The Central Hospital of Wuhan, Wuhan, Hubei, 430014, China.
Weiqun ChenKey Laboratory for Molecular Diagnosis of Hubei Province, The Central Hospital of Wuhan, Wuhan, Hubei, 430014, China.
Tangwei WuDepartment of Medical Laboratory, The Central Hospital of Wuhan, Wuhan, Hubei, 430014, China.
Shuiyi LiuDepartment of Medical Laboratory, The Central Hospital of Wuhan, Wuhan, Hubei, 430014, China.
Central Hospital of Wuhan · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AtherosclerosisCardiovascular DiseasesMicroRNAsRNA, Long NoncodingFoam CellsHigh Mobility Group ProteinsHumansRepressor ProteinsTumor Necrosis Factor-alphaHBP1 protein, humanHigh Mobility Group ProteinsHOTAIR long untranslated RNA, humanMicroRNAsMIRN19A microRNA, humanRepressor ProteinsRNA, Long NoncodingTumor Necrosis Factor-alphaAtherosclerosisFoam cellInflammatory factorLncRNA

Identifiers

PMID38250607
PMCPMC10797679
OpenAlexW4391036467

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.